Could single-Dose Zepbound Vials be a game-changer for weight loss?
August 2024- Eli Lilly and Company announced Zepbound ® (tirzepatide) 2.5 mg…
Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Adults with Pre-Diabetes and Obesity
INDIANAPOLIS- Eli Lilly and Company announced today positive topline results from the SURMOUNT-1…